Authors:
PAUS E
NILSSON O
BORMER OP
FOSSA SD
OTNES B
SKOVLUND E
Citation: E. Paus et al., STABILITY OF FREE AND TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM FROM PATIENTS WITH PROSTATE CARCINOMA AND BENIGN HYPERPLASIA, The Journal of urology, 159(5), 1998, pp. 1599-1605
Citation: E. Paus, HUMAN-RESOURCES AND THE ADJUSTMENT PROCESS - PAREDES,R, RIVEROS,LA, The Hispanic American historical review, 78(1), 1998, pp. 165-167
Authors:
HERNES EH
FOSSA SD
VAAGE S
OGREID P
HEILO A
PAUS E
Citation: Eh. Hernes et al., EPIRUBICIN COMBINED WITH ESTRAMUSTINE PHOSPHATE IN HORMONE-RESISTANT PROSTATE-CANCER - A PHASE-II STUDY, British Journal of Cancer, 76(1), 1997, pp. 93-99
Authors:
NAP M
VITALI A
NUSTAD K
BAST RC
OBRIEN TJ
NILSSON O
SEGUIN P
SURESH MR
BORMER OP
SAGA T
DEBRUIJN HWA
NOZAWA S
KREUTZ FT
JETTE D
SAKAHARA H
GADNELL M
ENDO K
BARLOW EH
WARREN D
PAUS E
HAMMARSTROM S
KENEMANS P
HILGERS J
Citation: M. Nap et al., IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL-ANTIBODIES AGAINST THE CA125 ANTIGEN - 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(6), 1996, pp. 325-331
Citation: E. Paus et At. Myklebust, EXPRESSION AND INTERCONVERSION OF NEURON-SPECIFIC ENOLASE IN PATIENT SERA AND EXTRACTS FROM SMALL-CELL LUNG-CANCER CELLS, Tumor biology, 17(5), 1996, pp. 271-280
Authors:
NUSTAD K
BAST RC
OBRIEN TJ
NILSSON O
SEGUIN P
SURESH MR
SAGA T
NOZAWA S
BORMER OP
DEBRUIJN HWA
NAP M
VITALI A
GADNELL M
CLARK J
SHIGEMASA K
KARLSSON B
KREUTZ FT
JETTE D
SAKAHARA H
ENDO K
PAUS E
WARREN D
HAMMARSTROM S
KENEMANS P
HILGERS J
Citation: K. Nustad et al., SPECIFICITY AND AFFINITY OF 26 MONOCLONAL-ANTIBODIES AGAINST THE CA-125 ANTIGEN - FIRST REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(4), 1996, pp. 196-219
Authors:
PELLIZZONI C
POGGESI I
JORGENSEN NP
EDWARDS DMF
PAUS E
BENEDETTI MS
Citation: C. Pellizzoni et al., PHARMACOKINETICS OF REBOXETINE IN HEALTHY-VOLUNTEERS, SINGLE AGAINST REPEATED ORAL DOSES AND LACK OF ENZYMATIC ALTERATIONS, Biopharmaceutics & drug disposition, 17(7), 1996, pp. 623-633
Citation: V. Nordvik et E. Paus, HOW MUCH DO HOME OWNERS PAY FOR THE SERVI CES OF THEIR DWELLING, Tidsskrift for samfunnsforskning, 37(3), 1996, pp. 392-405
Citation: E. Paus, SAFETY NETS, POLITICS, AND THE POOR - TRANSITIONS TO MARKET ECONOMIES- GRAHAM,C, The Journal of developing areas, 30(3), 1996, pp. 400-402
Authors:
ANDERSEN TI
PAUS E
NESLAND JM
MCKENZIE SJ
BORRESEN AL
Citation: Ti. Andersen et al., DETECTION OF C-ERBB-2 RELATED PROTEIN IN SERA FROM BREAST-CANCER PATIENTS - RELATIONSHIP TO ERBB2 GENE AMPLIFICATION AND C-ERBB-2 PROTEIN OVEREXPRESSION IN TUMOR, Acta oncologica, 34(4), 1995, pp. 499-504
Authors:
FRENGEN J
LINDMO T
PAUS E
SCHMID R
NUSTAD K
Citation: J. Frengen et al., DUAL ANALYTE ASSAY BASED ON PARTICLE TYPES OF DIFFERENT SIZE MEASUREDBY FLOW-CYTOMETRY, Journal of immunological methods, 178(1), 1995, pp. 141-151
Citation: D. Josefsen et al., INCREASE OF SERUM PROSTATIC SPECIFIC ANTIGEN AND CLINICAL PROGRESSIONIN PN-CANCER(MO PROSTATE), British Journal of Urology, 75(4), 1995, pp. 502-506
Authors:
BERNER A
WAERE H
NESLAND JM
PAUS E
DANIELSEN HE
FOSSA SD
Citation: A. Berner et al., DNA-PLOIDY, SERUM PROSTATE-SPECIFIC ANTIGEN, HISTOLOGICAL GRADE AND IMMUNOHISTOCHEMISTRY AS PREDICTIVE PARAMETERS OF LYMPH-NODE METASTASES IN T1-T3 MO PROSTATIC ADENOCARCINOMA/, British Journal of Urology, 75(1), 1995, pp. 26-32
Citation: Sd. Fossa et E. Paus, REDUCTION OF SERUM PROSTATE-SPECIFIC ANTIGEN DURING ENDOCRINE OR CYTOTOXIC TREATMENT OF HORMONE-RESISTANT CANCER OF THE PROSTATE - A PRELIMINARY-REPORT, European urology, 26(1), 1994, pp. 29-34
Citation: E. Paus et al., PROSTATE-SPECIFIC ANTIGEN IN SERUM FROM BLOOD-DONORS WITH SUBSEQUENT PROSTATE-CANCER DIAGNOSIS, European journal of cancer, 29A(8), 1993, pp. 1221-1222
Authors:
FRENGEN J
SCHMID R
KIERULF B
NUSTAD K
PAUS E
BERGE A
LINDMO T
Citation: J. Frengen et al., HOMOGENEOUS IMMUNOFLUOROMETRIC ASSAYS OF ALPHA-FETOPROTEIN WITH MACROPOROUS, MONOSIZED PARTICLES AND FLOW-CYTOMETRY, Clinical chemistry, 39(10), 1993, pp. 2174-2181